Why Do I Feel Tiered After 40

You’re not imagining it — feeling more tired after 40 is extremely common. Below I explain the main biological reasons, how growth hormone (GH) changes with age, why sermorelin often looks better than direct HGH for age‑related decline, and practical next steps you can take.

Why You Feel More Tired After 40

• Hormone shifts. Multiple hormones that support energy, recovery, and sleep decline or change rhythm with age, including growth hormone, testosterone or estrogen, and thyroid hormones. 
• Sleep architecture changes. Deep slow‑wave sleep, when large GH pulses occur, becomes shorter and more fragmented, reducing nightly repair and leaving you less refreshed. 
• Body composition and metabolism. Loss of lean mass and gain of visceral fat reduce metabolic efficiency and raise inflammation, both of which increase fatigue. 
• Lifestyle and comorbidities. Less activity, poorer sleep habits, medications, insulin resistance, depression, and chronic conditions become more common and amplify tiredness. 

How Growth Hormone Changes Over Time

• Pulsatile secretion and peak timing. GH is released in pulses, with the largest pulses during deep sleep. This pulsatility is central to its effects on muscle, fat, bone, and recovery. 
• Age‑related decline. GH secretion begins to fall after your 20s and continues across adulthood. By around age 60, daily GH output can be reduced by roughly half compared with younger adults. 
• Why it falls. Reduced slow‑wave sleep, increased visceral fat, insulin resistance, and low‑grade inflammation blunt pituitary GH pulses. This decline is usually a physiological part of aging rather than a disease. 

Sermorelin Versus Direct Hgh — How They Differ and Why Sermorelin Often “Outperforms” for Age‑related Decline

Mechanisms

• Sermorelin is a synthetic GHRH analog that stimulates your pituitary to release your own GH in natural pulses. This preserves the body’s feedback controls. 
• HGH (somatropin) is exogenous growth hormone injected directly into the bloodstream, bypassing the pituitary and the normal pulsatile pattern. 

Practical Differences and Tradeoffs

• Safety and regulation. Because sermorelin works through the pituitary and keeps feedback loops intact, it generally carries a lower risk of side effects such as fluid retention, insulin resistance, and pituitary suppression. 
• Speed and magnitude of effect. HGH produces faster and often larger changes in body composition and recovery, which can be useful for true GH deficiency, but it also has higher cost and higher long‑term risk. 
• Clinical context matters. For diagnosed adult GH deficiency from pituitary disease, direct GH replacement is an established therapy. For the gradual, physiological decline of aging, sermorelin’s stimulation of endogenous GH is often preferred because it is more physiological and safer for long‑term use. 

Evidence and Safety Notes

• Limited anti‑aging evidence. Trials of GH or secretagogues for otherwise healthy older adults are mixed and often short; long‑term safety and mortality effects are not well established. Major clinical bodies do not recommend GH simply for “anti‑aging” in healthy people. 
• When therapy is appropriate. Testing (IGF‑1 and, if indicated, stimulation tests) and specialist evaluation are required to distinguish true adult GH deficiency from normal age‑related decline before any prescription therapy. 

Practical Next Steps You Can Take Now

1. Get basic testing and a medical review. Ask your clinician about IGF‑1 and a full endocrine panel plus sleep and mental‑health screening. 
2. Prioritize sleep and exercise. Improve sleep hygiene and do regular resistance training and high‑intensity intervals to boost natural GH pulses. 
3. Nutrition and body composition. Reduce excess sugar, lose visceral fat if present, and ensure adequate protein and timing of meals to support GH release. 
4. If considering therapy, consult an endocrinologist. If tests show true GH deficiency or you’re weighing sermorelin versus HGH, a specialist can explain risks, monitoring, and realistic outcomes. 

 yes

Tests Your Doctor Will Likely Order and Why

• Serum IGF‑1 (age‑adjusted) — screens average GH activity over weeks; a low IGF‑1 raises suspicion but a normal IGF‑1 does not rule out deficiency. 
• GH stimulation test (one of: insulin tolerance test, macimorelin, glucagon stimulation) — required to confirm adult GH deficiency because random GH values are unreliable. Each test has validated cutoffs used by endocrinologists. 
• Baseline pituitary panel — TSH, free T4, morning cortisol, LH/FSH, sex hormones (testosterone or estradiol), prolactin to check for other pituitary hormone deficits or causes. 
• Metabolic labs — fasting glucose or HbA1c, fasting lipids, CMP (liver/kidney electrolytes) to assess insulin sensitivity, lipids, and safety before any hormone therapy. 
• IGFBP‑3 (sometimes) and repeat IGF‑1 on the same assay if results are borderline — IGF‑1 assays vary between labs, so interpretation requires age‑matched reference ranges and consistent assays. 
• Pituitary MRI (if biochemical testing suggests deficiency or if there’s history of pituitary disease, head trauma, surgery, or radiotherapy). 

What Each Test Tells You (Brief)

• IGF‑1: a stable marker reflecting recent GH exposure; high specificity, low sensitivity — many people with true GHD can have normal IGF‑1. 
• Stimulation tests: directly measure pituitary capacity to release GH; diagnostic standard for adult GHD. 
• Pituitary panel & MRI: identify other hormone problems or structural causes that would change management. 

Typical Thresholds and Interpretation (Overview)

• IGF‑1: interpreted against age‑adjusted reference ranges; a low IGF‑1 increases pretest probability but is not definitive. 
• GH stimulation tests: each test has its own diagnostic cutoff (e.g., macimorelin and insulin tolerance test cutoffs are defined in guidelines); an endocrinologist interprets results in clinical context. 

Sermorelin, Hgh, and Testing Relevance

• Sermorelin is a GHRH analog that stimulates endogenous, pulsatile GH release and is often used off‑label for age‑related decline; it tends to preserve feedback control compared with exogenous HGH. Clinical use, dosing, and stacking strategies are discussed in practice and commercial sources, but long‑term safety and anti‑aging benefit remain uncertain. 
• Important safety note: GH or secretagogues should only be used under medical supervision after appropriate testing; they can affect glucose metabolism, fluid balance, and other hormones. 

Short Checklist to Bring to Your Appointment

• Symptoms list (concise, dated): fatigue pattern, sleep changes, exercise tolerance, libido, mood, weight/body‑composition changes.
• Medication list (including OTC, supplements, peptides, and recent steroids).
• Relevant medical history: head trauma, pituitary tumor/surgery, cranial irradiation, childhood GH therapy, other endocrine diagnoses.
• Recent labs (if any) and the name of the lab that ran them (assay differences matter).
• Questions to ask (bring printed): “Do my symptoms and labs warrant GH stimulation testing?”; “If GH deficiency is confirmed, what are the treatment options, risks, and monitoring plan?”
• Insurance/authorization info and a photo ID.

What to Expect During Evaluation and Next Steps

• Step 1: clinician reviews history, performs baseline labs (IGF‑1, pituitary panel, metabolic labs). 
• Step 2: if suspicion remains, you’ll be referred for a GH stimulation test or to an endocrinologist; if indicated, a pituitary MRI may follow. 
• Step 3: if true adult GHD is diagnosed, treatment options (recombinant GH vs other approaches) and monitoring plans are discussed; therapy requires regular bloodwork and clinical follow‑up. 

Practical Lifestyle Steps You Can Start Now

• Improve sleep quality (consistent schedule, reduce late carbs/alcohol, treat sleep apnea if present).
• Resistance training and interval exercise to boost natural GH pulses and preserve lean mass.
• Reduce visceral fat through diet and activity, insulin resistance and adiposity blunt GH secretion.
• Optimize protein intake and avoid late high‑carb meals near bedtime (insulin blunts GH release). 

Final Notes and Safety Reminders

• Adult GH deficiency is uncommon and requires specialist confirmation; many age‑related symptoms overlap with normal aging and other conditions. 
• Do not start peptides or HGH without prescription and endocrine oversight; unsupervised use risks metabolic and other harms and may have legal or anti‑doping implications for athletes.